Frontiers in Microbiology (Dec 2024)

IRF7-deficient MDBK cell based on CRISPR/Cas9 technology for enhancing IBRV replication

  • Guiyang Ge,
  • Dongli Li,
  • Qian Ling,
  • Lihui Xu,
  • Emad Beshir Ata,
  • Xiaolin Wang,
  • Keyan Li,
  • Wen Hao,
  • Qinglong Gong,
  • Jianming Li,
  • Kun Shi,
  • Xue Leng,
  • Rui Du

DOI
https://doi.org/10.3389/fmicb.2024.1483527
Journal volume & issue
Vol. 15

Abstract

Read online

Infectious bovine rhinotracheitis (IBR), characterized by acute respiratory lesions in cattle, is a major infectious disease caused by bovine alphaherpesvirus-1 (BoAHV-1). Control of this disease is primarily depending on vaccination. Madin-Darby bovine kidney cells (MDBK) being the main host cells and the important production platform for IBR vaccines. However, innate immune genes inhibit viral replication. Accordingly, the aim of this study was developing of IRF7 gene deleted MDBK cells to facilitate the production of high-titer vaccines. The CRISPR/Cas9 technology was used to knock out the IRF7 gene in MDBK cells and the impact on virus replication was examined using virus growth curves, CCK-8 assays, cell scratch assays, and qPCR. The knockout of the IRF7 gene in MDBK cells led to an increased replication capacity of IBRV and a significant reduction in type I interferons expression, specifically IFN-α and IFN-β. This indicates that IRF7−/−MDBK cell lines can effectively result in production of IBRV with high-titer, which will enhance the development of inactivated or attenuated vaccines.

Keywords